RxDoctor Payments Data

Brian Dickens, DO

Family Medicine · Roanoke, VANPI 1770794885

Payments from drug & device makers

$695in general payments, 2019–2025

Across 37 payments — averaging $18.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$163
  • Johnson & Johnson$97
  • Pfizer$67
  • Novo Nordisk$67
  • Biohaven Pharmaceutical Holding Company Ltd.$53
  • Takeda Pharmaceuticals U.S.A., Inc.$46
  • plus $201 from 10 others

What the payments were for

  • Food & beverage$695100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$695 in reported general payments places this provider in the 60th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$18,540
Medicare patients
61
Services billed
263

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide14$16,904
Duloxetine Hcl13$568
Atorvastatin Calcium27$335
Lisinopril26$230
Levothyroxine Sodium14$137
Metformin Hcl24$131
Allopurinol11$116
Montelukast Sodium13$106
Amlodipine Besylate32$101
Losartan Potassium16$86
Metoprolol Succinate12$67
Rosuvastatin Calcium12$39

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$23$16,90414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Roanoke

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →